Next-generation synthetic trials in hematology with generative artificial intelligence

Generative AI is revolutionizing clinical hematology by creating high-fidelity synthetic patient cohorts that mirror complex blood disorder data. This advancement significantly reduces the reliance on traditional trial recruitment, potentially accelerating the approval process for life-saving hematological therapies.